Edition:
United Kingdom

Proteostasis Therapeutics Inc (PTI.OQ)

PTI.OQ on NASDAQ Stock Exchange Global Market

4.75USD
7:28pm GMT
Change (% chg)

$-0.72 (-13.16%)
Prev Close
$5.47
Open
$5.15
Day's High
$5.28
Day's Low
$4.65
Volume
2,365,215
Avg. Vol
130,942
52-wk High
$16.65
52-wk Low
$1.41

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -0.68 December 14 Dec 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 2 2 2 2
(2) OUTPERFORM 1 1 1 1
(3) HOLD 1 1 1 1
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 1.75 1.75 1.75 1.75

Consensus Estimates Analysis

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 3 1.42 1.60 1.10 --
Quarter Ending Mar-18 1 1.00 1.00 1.00 0.00
Year Ending Dec-17 3 5.13 5.30 4.82 2.30
Year Ending Dec-18 3 2.47 5.40 0.00 4.10
Earnings (per share)
Quarter Ending Dec-17 3 -0.68 -0.61 -0.72 -0.63
Quarter Ending Mar-18 2 -0.60 -0.49 -0.70 -0.61
Year Ending Dec-17 3 -2.56 -2.44 -2.69 -2.42
Year Ending Dec-18 4 -2.51 -1.89 -2.99 -2.76

Historical Surprises

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
Estimates vs Actual Estimate Actual Difference Surprise %
SALES (in millions)
Quarter Ending Sep-17 1.16 1.55 0.39 34.05
Quarter Ending Jun-17 0.75 1.15 0.39 52.12
Quarter Ending Mar-17 0.26 1.02 0.76 294.21
Quarter Ending Dec-16 1.29 4.06 2.77 214.48
Quarter Ending Sep-16 0.75 1.72 0.97 130.20

Consensus Estimates Trend

Sales and Profit Figures in US Dollar (USD)
Earnings and Dividend Figures in US Dollar (USD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Quarter Ending Dec-17 1.42 1.42 1.07 1.07 --
Quarter Ending Mar-18 1.00 -- -- -- 0.00
Year Ending Dec-17 5.13 5.13 3.30 3.30 2.30
Year Ending Dec-18 2.47 2.47 1.00 1.00 4.10

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Quarter Ending Dec-17 0 0 1 0
Quarter Ending Mar-18 -- -- -- --
Year Ending Dec-17 0 0 2 0
Year Ending Dec-18 0 0 0 0
Earnings